Flowcytometric analysis of tumor tissues showed that shSGLT2 significantly reduced the expression of PD-L1 (Figure 6J) and boosted the population of activated tumor-infiltrated CD3+ and CD8+ T cells (Figure 6, K and L). The gene discussed is CD8A; the disease is neoplasm.